Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The primary purpose of this study is to measure the efficacy of solifenacin succinate (VESIcare) on treating urinary incontinence in Parkinson\'s disease patients. The secondary objective of this study is to examine the effect of solifenacin succinate (VESIcare) on symptoms of PD and the patient\'s quality of life.
Epistemonikos ID: d8581175c87cebd6f623d89ce1c6baf046ba8f9e
First added on: May 04, 2024